Brixton_Logo_Final_BlackonWhite.jpg
Brixton Metals Reduces Royalties at its Thorn Project Through a Purchase Agreement with Kohima Pacific Gold
June 20, 2024 07:30 ET | Brixton Metals Corporation
VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce that it has entered into a...
ProSearch Logo.png
ProSearch Adds Intelligent Voice to Its Arsenal of Industry-leading Tools to Optimize Discovery
June 17, 2024 09:00 ET | ProSearch
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- ProSearch, a leading provider of comprehensive data intelligence, discovery, and compliance solutions to corporate legal departments and law firms,...
evergold_logo.png
Evergold Closes $1,072,000 Private Placement to Support Follow-up Drilling at Emerging DEM1 Gold-Silver++ Discovery, BC
June 12, 2024 07:00 ET | Evergold Corp.
Evergold Closes $1,072,000 Private Placement to Support Follow-up Drilling at Emerging DEM1 Gold-Silver++ Discovery, BC
LPR_Logo_K.png
London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
June 10, 2024 14:33 ET | London Research and Pharmaceuticals
London Research & Pharmaceuticals Presents Advancement of LRP-661, Their Lead Drug Candidate, at the New Antiepileptic Drug Conference in Madrid, Spain
Chris Dahl Headshot
ProSearch Expands Client-Focused Leadership Team Amid Continued Growth
June 05, 2024 10:00 ET | ProSearch
LOS ANGELES, June 05, 2024 (GLOBE NEWSWIRE) -- ProSearch, a leading provider of legal data intelligence and comprehensive discovery and compliance solutions to corporate legal departments and law...
Figure 1 - CSAMT Survey Lines on TMI
Evergold – CSAMT Survey Over DEM1 Prospect, B.C., Reveals Large Target Extending Across All Lines and to Depth Below Reconnaissance Drill Holes
May 13, 2024 07:00 ET | Evergold Corp.
CSAMT Survey Over Evergold's DEM1 Prospect, B.C., Reveals Large Target Extending Across All Lines and to Depth Below Reconnaissance Drill Holes
QuisLex-Logo-NEW.jpg
QuisLex Incorporates ContractPodAi’s Leah Generative AI Platform into Its Workflows
April 30, 2024 11:00 ET | QuisLex
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- QuisLex, a leading alternative legal services provider long recognized as a pioneer in the industry, announced today its expanded partnership with...
LPR_Logo_K.png
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
April 15, 2024 08:00 ET | London Research and Pharmaceuticals
London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference
OBT-RGB_1417_544 (2).jpg
Oxford BioTherapeutics Announces Launch of Enhanced Discovery Platform, OGAP®-Verify, at World ADC Conference 2024
March 07, 2024 04:00 ET | Oxford BioTherapeutics
OGAP®-Verify allows for significantly enhanced sensitivity and specificity for improved target selection, dramatically accelerating drug target discoveryOGAP-Verify is now more sensitive than...
STELMINE.png
Stelmine is planning a maiden exploration campaign on its northern Caniapiscau properties
March 04, 2024 09:55 ET | Stelmine Canada Ltd.
QUÉBEC CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Stelmine Canada (“Stelmine” or “the Company”) (TSXV: STH). Stelmine is currently planning its summer 2024 work program. This year, a first...